Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-07-02Clinical Trial Update: Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)
A non-interventional study evaluating oral vinorelbine in patients with advanced non-small cell lung cancer and metastatic breast cancer has…
-
CLINICAL_TRIALS withdrawal · 2012-06-29Clinical Trial Update: Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating tipifarnib in combination with trastuzumab for metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 trial update evaluating bevacizumab with liposomal doxorubicin in women with locally recurrent or metastatic breast cancer has compl…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of docetaxel, gemcitabine, and bevacizumab in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer [Phase 1]
Phase 1b/2a open-label study evaluating tivozanib in combination with paclitaxel in advanced or metastatic breast cancer. The trial has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer [Phase 2]
This document reports results from a randomized Phase II induction-therapy trial for early-stage breast cancer; the trial status is complete…
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in Women
A completed Mayo Clinic trial evaluated vibro-acoustography imaging for detecting breast microcalcifications and lesions in women.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) [Phase 2]
Phase 2 trial evaluating a one-step sentinel lymph node biopsy using radiolabeled methylene blue in breast cancer completed with results pos…
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients [Phase 2]
Phase 2 trial assessing curcumin to prevent radiation-induced dermatitis in breast cancer patients. The study has completed and results were…
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: Mindfulness-based Stress Reduction in Breast Cancer Recovery [NA]
A clinical trial investigating mindfulness-based stress reduction for breast cancer recovery has completed. The record provides sponsor and …
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer
A completed clinical trial evaluating how 18F-FDG PET-Scan contributes to determining tumor volume in patients who had surgery for breast ca…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™) [Phase 2]
Phase II neoadjuvant trial evaluating trastuzumab combined with dose-dense Abraxane in breast cancer has completed enrollment with results p…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating radiation therapy using gold markers for women with early-stage breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study
This clinical trial update reports the completed study evaluating AlloMax for immediate expander-based breast reconstruction after mastectom…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer [Phase 2]
A Phase 2 study evaluated chemotherapy with filgrastim and stem cell transplantation with radiation therapy in patients with stage III or st…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer [Phase 2]
Phase 2 study comparing exemestane plus dasatinib versus placebo in advanced estrogen receptor-positive breast cancer to evaluate safety and…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy [Phase 2]
Phase 2 trial evaluating high-dose esterified estrogens for postmenopausal women with metastatic breast cancer that progressed after prior h…
-
CLINICAL_TRIALS withdrawal · 2012-06-11Clinical Trial Update: Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer [Phase 2]
The Phase 2 trial evaluating trastuzumab in combination with exemestane for postmenopausal women with metastatic or locally advanced breast …
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Improving Communication With Patients With Breast Cancer [NA]
A Northwestern University trial investigating improved communication with patients who have breast cancer has been terminated.
-
FDA approval · 2012-06-08FDA Approved: PERJETA — Original Application (Genentech, Inc.)
The FDA approved PERJETA (pertuzumab) from Genentech as the original application for the treatment of HER2-positive metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study [Phase 1]
Phase 1 PK/PD study of BIIB021 (CNF2024) in combination with Herceptin for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer [Phase 3]
A phase 3 clinical trial comparing paclitaxel with or without gemcitabine in women with advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Feasibility of Ambulatory Surgery for Early Breast Cancer [NA]
The trial completed a feasibility assessment of ambulatory (outpatient) surgery for patients with early breast cancer, including its impact …
-
CLINICAL_TRIALS withdrawal · 2012-06-07Clinical Trial Update: BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer [Phase 2]
The Phase 2 BEZ235 (dactolisib) trial in HER2-negative, HR-positive metastatic breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer [Phase 3]
Phase 3 trial comparing fulvestrant (Faslodex) to tamoxifen (Nolvadex) in postmenopausal women with advanced/metastatic breast cancer.